https://doi.org/10.1056/nejm199112123252403
E
Eitan Friedman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
743
Papers
32.7K
Citations
89
h-index
444
i10-index
Eitan Friedman is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: BRCA gene mutations in cancer & Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics. The author has an h-index of 89, co-authored 632 publications.
ORCID: 0000-0002-6745-1733Papers by this author
worksActivating Mutations of the Stimulatory G Protein in the McCune–Albright Syndrome
1991 · New England Journal of Medicine · 1,684 citations
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
2020 · Nature Genetics · 551 citations
https://doi.org/10.1038/s41588-020-0609-2
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
2013 · Nature Genetics · 537 citations
https://doi.org/10.1038/ng.2566
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
2015 · JAMA · 494 citations
https://doi.org/10.1001/jama.2014.5985
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
2017 · Nature Genetics · 464 citations
https://doi.org/10.1038/ng.3785
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
2013 · PLoS Genetics · 390 citations
https://doi.org/10.1371/journal.pgen.1003212
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat